Gemcitabine in advanced biliary tract cancers
Author:
Publisher
Elsevier BV
Subject
Oncology,Hematology
Reference62 articles.
1. Biliary tract cancers: current concepts and controversies;Leonard;Expert Opin Pharmacother,2005
2. Weekly gemcitabine in advanced bladder cancer: a preliminary report from a phase I study;Pollera;Ann Oncol,1994
3. Phase I and pharmacokinetic trial of gemcitabine in patients with hepatic or renal dysfunction: Cancer and Leukemia Group B 9565;Venook;J Clin Oncol,2000
4. Toxicity of a 24-hour infusion of gemcitabine in biliary tract and pancreatic cancer: a pilot study;Eckel;Cancer Invest,2002
5. Maximum-tolerated dose defined for single-agent gemcitabine: a phase I dose-escalation study in chemotherapy-naive patients with advanced non-small-cell lung cancer;Fossella;J Clin Oncol,1997
Cited by 19 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. A randomized, multicenter, phase II study of vandetanib monotherapy versus vandetanib in combination with gemcitabine versus gemcitabine plus placebo in subjects with advanced biliary tract cancer: the VanGogh study;Annals of Oncology;2015-03
2. Advances in systemic therapy for advanced pancreatobiliary malignancies;F1000Research;2013-04-08
3. Gemcitabine Alone or in Combination with Cisplatin for Advanced Biliary Tract Carcinomas: an Overview of Clinical Evidence;Asian Pacific Journal of Cancer Prevention;2013-02-28
4. Human equilibrative nucleoside transporter 1 level does not predict prognosis in pancreatic cancer patients treated with neoadjuvant chemoradiation including gemcitabine;Journal of Hepato-Biliary-Pancreatic Sciences;2012-03-17
5. Involvement of Phosphatidylinositol 3-Kinase/Akt Pathway in Gemcitabine-Induced Apoptosis-Like Cell Death in Insulinoma Cell Line INS-1;Biological and Pharmaceutical Bulletin;2012
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3